Virtu Financial’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Virtu Financial’s Portfolio SRTAW Stock Details SRTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-184,292	Closed	-$1K	–	1619
2026 Q1	$1K	Buy	184,292 +58,391	+46%	+$4.41K	﹤0.01%	1549
2025 Q4	$13K	Buy	125,901 +39,663	+46%	+$6.58K	﹤0.01%	1482
2025 Q3	$17K	Buy	86,238 +4,307	+5%	+$845	﹤0.01%	1294
2025 Q2	$17K	Buy	81,931 +17,231	+27%	+$3.33K	﹤0.01%	1267
2025 Q1	$14K	Buy	64,700 +24,343	+60%	+$8.08K	﹤0.01%	1148
2024 Q4	$17K	Buy	+40,357	New	+$13.5K	﹤0.01%	1318
2022 Q2	–	Sell	-24,390	Closed	-$50K	–	1599
2022 Q1	$50K	Buy	24,390 +7,737	+46%	+$12.2K	﹤0.01%	1133
2021 Q4	$37K	Buy	+16,653	New	+$40.7K	﹤0.01%	1406

Virtu Financial's SRTAW Position: Q2 2026 in Review

Virtu Financial sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q2 2026, closing a stake of 184,292 shares — an estimated $1K sold.

Virtu Financial first reported a position in SRTAW in Q4 2021 and held it in 8 quarters. The position peaked at $50K in Q1 2022. 0 funds tracked by Wall St. Rank hold SRTAW as of Q2 2026.

Virtu Financial reported no remaining Strata Critical Medical Inc Warrants position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 184,292 Strata Critical Medical Inc Warrants shares in Q2 2026, an estimated $1K.
Virtu Financial first reported a position in Strata Critical Medical Inc Warrants in Q4 2021 and held it in 8 quarters.
Virtu Financial's Strata Critical Medical Inc Warrants position peaked at $50K in Q1 2022.
0 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.